LAMIVUDINE AND ZIDOVUDINE

7705 reported adverse events

Drug classes: Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

These side effects are most commonly reported by patients taking LAMIVUDINE AND ZIDOVUDINE:

# Side effect Count
0 DRUG EXPOSURE DURING PREGNANCY 1147
1 FOETAL EXPOSURE DURING PREGNANCY 720
2 PAIN 601
3 ANXIETY 568
4 EMOTIONAL DISTRESS 557
5 ANHEDONIA 504
6 ANAEMIA 453
7 ABORTION SPONTANEOUS 443
8 MATERNAL EXPOSURE DURING PREGNANCY 381
9 PREMATURE BABY 363
See all common reactions for LAMIVUDINE AND ZIDOVUDINE

LAMIVUDINE AND ZIDOVUDINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SPINOCEREBELLAR DISORDER 18 0.3830
1 CARDIAC MALPOSITION 19 0.2500
2 DANDY-WALKER SYNDROME 57 0.2201
3 ALPHA 1 FOETOPROTEIN ABNORMAL 22 0.2200
4 CHORIOAMNIONITIS 20 0.1053
5 MACROCEPHALY 40 0.1031
6 CEREBELLAR HYPOPLASIA 17 0.1012
7 ULTRASOUND ANTENATAL SCREEN ABNORMAL 22 0.1000
8 BONE DEMINERALISATION 96 0.0907
9 MITOCHONDRIAL CYTOPATHY 35 0.0795
See all enriched reactions for LAMIVUDINE AND ZIDOVUDINE